Hualan Biological Engineering Inc
SZSE:002007

Watchlist Manager
Hualan Biological Engineering Inc Logo
Hualan Biological Engineering Inc
SZSE:002007
Watchlist
Price: 17.19 CNY -2.55% Market Closed
Market Cap: 31.4B CNY
Have any thoughts about
Hualan Biological Engineering Inc?
Write Note

Balance Sheet

Balance Sheet Decomposition
Hualan Biological Engineering Inc

Current Assets 9B
Cash & Short-Term Investments 5B
Receivables 2B
Other Current Assets 2B
Non-Current Assets 6.6B
Long-Term Investments 3B
PP&E 3B
Intangibles 346.4m
Other Non-Current Assets 275.2m
Current Liabilities 2.3B
Accounts Payable 198.3m
Accrued Liabilities 813.6m
Short-Term Debt 912m
Other Current Liabilities 410.4m
Non-Current Liabilities 2.1B
Long-Term Debt 8.6m
Other Non-Current Liabilities 2B

Balance Sheet
Hualan Biological Engineering Inc

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
672
363
486
198
425
602
962
671
1 097
989
Cash
4
7
6
3
3
3
5
671
1 097
989
Cash Equivalents
668
356
480
195
422
599
957
0
0
0
Short-Term Investments
0
0
0
0
0
2 307
2 986
2 659
2 954
4 029
Total Receivables
343
617
448
949
1 093
1 135
2 274
2 104
2 415
2 597
Accounts Receivables
153
126
289
778
910
965
1 754
1 830
2 232
2 296
Other Receivables
190
491
159
171
183
170
520
274
183
301
Inventory
475
598
921
1 211
1 204
1 160
1 175
1 359
1 447
1 674
Other Current Assets
1 017
1 072
1 328
1 311
2 061
481
116
58
166
38
Total Current Assets
2 506
2 650
3 182
3 669
4 782
5 685
7 512
6 851
8 077
9 327
PP&E Net
990
1 115
1 196
1 201
1 312
1 449
1 987
2 508
2 407
2 884
PP&E Gross
990
1 115
1 196
1 201
1 312
1 449
1 987
2 508
2 407
2 884
Accumulated Depreciation
547
653
782
913
1 036
1 178
1 340
1 493
1 534
1 759
Intangible Assets
206
200
211
210
217
216
215
227
334
346
Goodwill
0
0
0
0
1
1
1
1
1
1
Long-Term Investments
37
29
19
68
91
105
110
1 716
3 673
3 273
Other Long-Term Assets
29
28
42
71
90
127
214
234
251
275
Other Assets
0
0
0
0
1
1
1
1
1
1
Total Assets
3 770
N/A
4 021
+7%
4 650
+16%
5 219
+12%
6 493
+24%
7 583
+17%
10 039
+32%
11 537
+15%
14 743
+28%
16 106
+9%
Liabilities
Accounts Payable
43
44
63
68
65
65
91
217
160
197
Accrued Liabilities
7
11
14
17
11
13
30
949
1 072
1 170
Short-Term Debt
0
0
0
0
0
0
471
824
815
702
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
10
0
300
Other Current Liabilities
84
82
138
292
644
617
1 324
215
101
212
Total Current Liabilities
134
137
215
377
720
694
1 917
2 215
2 148
2 581
Long-Term Debt
0
0
0
0
0
0
0
190
309
9
Deferred Income Tax
0
0
0
0
0
5
4
10
21
43
Minority Interest
234
226
217
175
245
341
572
727
1 812
2 062
Other Liabilities
0
0
0
0
0
0
17
58
54
51
Total Liabilities
367
N/A
364
-1%
433
+19%
553
+28%
966
+75%
1 040
+8%
2 510
+141%
3 200
+28%
4 345
+36%
4 746
+9%
Equity
Common Stock
581
581
930
930
930
1 403
1 824
1 824
1 824
1 829
Retained Earnings
2 454
2 694
2 893
3 342
4 203
4 644
5 696
6 448
7 159
8 093
Additional Paid In Capital
367
382
395
395
395
496
102
106
1 415
1 486
Treasury Stock
0
0
0
0
0
0
94
41
0
48
Total Equity
3 402
N/A
3 658
+8%
4 218
+15%
4 667
+11%
5 527
+18%
6 543
+18%
7 529
+15%
8 337
+11%
10 398
+25%
11 359
+9%
Total Liabilities & Equity
3 770
N/A
4 021
+7%
4 650
+16%
5 219
+12%
6 493
+24%
7 583
+17%
10 039
+32%
11 537
+15%
14 743
+28%
16 106
+9%
Shares Outstanding
Common Shares Outstanding
1 814
1 814
1 814
1 814
1 814
1 824
1 824
1 823
1 824
1 824

See Also

Discover More